A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.

CONCLUSION: These results confirm (1) that there is a preferential use of TPO-RAs in elderly ITP patients with fewer bleeding complications but more unfavorable prothrombotic conditions than in younger individuals, and (2) that early use of these agents has been established as an effective therapeutic alternative to other second line therapies.
PMID: 32979651 [PubMed - as supplied by publisher]

Source: Blood Cells, Molecules and Diseases - September 19, 2020 Category: Hematology Authors: Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM, González-López TJ, Carreño-Tarragona G, Bermejo N, Lopez-Fernandez MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, González-Porras JR, Bol Tags: Blood Cells Mol Dis Source Type: research